Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial-Reference-Cited by-同舟云学术

Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial

Published:2024-02-19 Issue:4 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Guo Xi¹,Lou Wenhui²,Xu Yaolin²,Zhuang Rongyuan¹,Yao Lie³,Wu Junwei⁴,Fu Deliang³,Zhang Jun⁴,Liu Jing⁴,Rong Yefei²,Jin Dayong²,Wu Wenchuan²,Xu Xuefeng²,Ji Yuan⁵,Wu Lili⁶,Lv Minzhi⁷,Yao Xiuzhong⁸,Liu Xiaowei⁹,Wang Dansong²,Kuang Tiantao²,Liu Liang²,Wang Wenquan²,Liu Tianshu¹,Zhou Yuhong¹

Affiliation:

1. Department of Medical Oncology, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, P.R. China

2. Department of General Surgery, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, P.R. China

3. Department of Pancreatic Surgery, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, P.R. China

4. Oncology Department, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, P.R. China

5. Department of Pathology, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, P.R. China

6. Department of Radiotherapy, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, P.R. China

7. Department of Biostatistics, Clinical Research Unit, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, P.R. China

8. Department of Radiology, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, P.R. China

9. Department of Anti‑tumor Business, Shi Yao Group European Pharmaceutical Co., Ltd., Shijiazhuang, Hebei 050035, P.R. China

Publisher

Spandidos Publications

Reference44 articles.

1. Pancreatic cancer;Mizrahi;Lancet,2020

2. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

3. The American Cancer Society's facts & figures: 2020 Edition;Viale;J Adv Pract Oncol,2020

4. Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020;Cao;Chin Med J (Engl),2021

5. Pancreatic cancer;Kamisawa;Lancet,2016